Clinical study of Jianpi Qingchang decoction in the treatment of ulcerative colitis patients with spleen deficiency and dampness-heat syndrome accompanied by fatigue: Study protocol for a randomized controlled trial

Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of U...

Full description

Saved in:
Bibliographic Details
Published inContemporary clinical trials communications Vol. 42; p. 101409
Main Authors Liu, Zi-Xuan, Liu, Xiao-Yan, Tan, Wei-wei, Zhang, Wei-Bing, Zhang, Ya-Li, Zheng, Lie, Dai, Yan-Cheng
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.12.2024
Elsevier
Subjects
Online AccessGet full text
ISSN2451-8654
2451-8654
DOI10.1016/j.conctc.2024.101409

Cover

Abstract Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue. The investigation will focus on assessing the impact of JPQC on the gut microbiota and metabolites in these patients, aiming to elucidate the regulatory mechanism that JPQC exerts on the gut microbiota and metabolites in the context of UC-related fatigue. In this randomized clinical trial, 140 subjects diagnosed with UC will be recruited and randomized into two groups. They will receive either JPQC combined with mesalazine or mesalazine alone for 12 weeks. Follow-up visits will be conducted every four weeks, with a post-treatment visit scheduled at 6 months. The primary outcome measures include the Inflammatory bowel disease fatigue scale(IBD-F). Secondary efficacy indicators comprise the assessment of TCM syndrome and individual syndrome efficacy before and after treatment, Modified Mayo score, Simple clinical colitis activity index (SCCAI), as well as the Inflammatory Bowel Disease Questionnaire (IBDQ) for each group. The other outcomes are the Intestinal microbial diversity and non-targeted metabonomics, which will be measured at baseline and 12 weeks after randomization. If effective, JPQC will provide substantial clinical evidence concerning the effectiveness and safety in the treatment of patients with UC experiencing spleen deficiency and dampness-heat syndrome accompanied by fatigue. ChiCTR2300068348.
AbstractList Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue. The investigation will focus on assessing the impact of JPQC on the gut microbiota and metabolites in these patients, aiming to elucidate the regulatory mechanism that JPQC exerts on the gut microbiota and metabolites in the context of UC-related fatigue. In this randomized clinical trial, 140 subjects diagnosed with UC will be recruited and randomized into two groups. They will receive either JPQC combined with mesalazine or mesalazine alone for 12 weeks. Follow-up visits will be conducted every four weeks, with a post-treatment visit scheduled at 6 months. The primary outcome measures include the Inflammatory bowel disease fatigue scale(IBD-F). Secondary efficacy indicators comprise the assessment of TCM syndrome and individual syndrome efficacy before and after treatment, Modified Mayo score, Simple clinical colitis activity index (SCCAI), as well as the Inflammatory Bowel Disease Questionnaire (IBDQ) for each group. The other outcomes are the Intestinal microbial diversity and non-targeted metabonomics, which will be measured at baseline and 12 weeks after randomization. If effective, JPQC will provide substantial clinical evidence concerning the effectiveness and safety in the treatment of patients with UC experiencing spleen deficiency and dampness-heat syndrome accompanied by fatigue. ChiCTR2300068348.
Background: Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under ''dysentery'' and ''intestinal bleeding'' in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue. The investigation will focus on assessing the impact of JPQC on the gut microbiota and metabolites in these patients, aiming to elucidate the regulatory mechanism that JPQC exerts on the gut microbiota and metabolites in the context of UC-related fatigue. Methods: In this randomized clinical trial, 140 subjects diagnosed with UC will be recruited and randomized into two groups. They will receive either JPQC combined with mesalazine or mesalazine alone for 12 weeks. Follow-up visits will be conducted every four weeks, with a post-treatment visit scheduled at 6 months. The primary outcome measures include the Inflammatory bowel disease fatigue scale(IBD-F). Secondary efficacy indicators comprise the assessment of TCM syndrome and individual syndrome efficacy before and after treatment, Modified Mayo score, Simple clinical colitis activity index (SCCAI), as well as the Inflammatory Bowel Disease Questionnaire (IBDQ) for each group. The other outcomes are the Intestinal microbial diversity and non-targeted metabonomics, which will be measured at baseline and 12 weeks after randomization. Discussion: If effective, JPQC will provide substantial clinical evidence concerning the effectiveness and safety in the treatment of patients with UC experiencing spleen deficiency and dampness-heat syndrome accompanied by fatigue. Trial registration: ChiCTR2300068348.
Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue. The investigation will focus on assessing the impact of JPQC on the gut microbiota and metabolites in these patients, aiming to elucidate the regulatory mechanism that JPQC exerts on the gut microbiota and metabolites in the context of UC-related fatigue.BackgroundUlcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue. The investigation will focus on assessing the impact of JPQC on the gut microbiota and metabolites in these patients, aiming to elucidate the regulatory mechanism that JPQC exerts on the gut microbiota and metabolites in the context of UC-related fatigue.In this randomized clinical trial, 140 subjects diagnosed with UC will be recruited and randomized into two groups. They will receive either JPQC combined with mesalazine or mesalazine alone for 12 weeks. Follow-up visits will be conducted every four weeks, with a post-treatment visit scheduled at 6 months. The primary outcome measures include the Inflammatory bowel disease fatigue scale(IBD-F). Secondary efficacy indicators comprise the assessment of TCM syndrome and individual syndrome efficacy before and after treatment, Modified Mayo score, Simple clinical colitis activity index (SCCAI), as well as the Inflammatory Bowel Disease Questionnaire (IBDQ) for each group. The other outcomes are the Intestinal microbial diversity and non-targeted metabonomics, which will be measured at baseline and 12 weeks after randomization.MethodsIn this randomized clinical trial, 140 subjects diagnosed with UC will be recruited and randomized into two groups. They will receive either JPQC combined with mesalazine or mesalazine alone for 12 weeks. Follow-up visits will be conducted every four weeks, with a post-treatment visit scheduled at 6 months. The primary outcome measures include the Inflammatory bowel disease fatigue scale(IBD-F). Secondary efficacy indicators comprise the assessment of TCM syndrome and individual syndrome efficacy before and after treatment, Modified Mayo score, Simple clinical colitis activity index (SCCAI), as well as the Inflammatory Bowel Disease Questionnaire (IBDQ) for each group. The other outcomes are the Intestinal microbial diversity and non-targeted metabonomics, which will be measured at baseline and 12 weeks after randomization.If effective, JPQC will provide substantial clinical evidence concerning the effectiveness and safety in the treatment of patients with UC experiencing spleen deficiency and dampness-heat syndrome accompanied by fatigue.DiscussionIf effective, JPQC will provide substantial clinical evidence concerning the effectiveness and safety in the treatment of patients with UC experiencing spleen deficiency and dampness-heat syndrome accompanied by fatigue.ChiCTR2300068348.Trial registrationChiCTR2300068348.
AbstractBackgroundUlcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue. The investigation will focus on assessing the impact of JPQC on the gut microbiota and metabolites in these patients, aiming to elucidate the regulatory mechanism that JPQC exerts on the gut microbiota and metabolites in the context of UC-related fatigue. MethodsIn this randomized clinical trial, 140 subjects diagnosed with UC will be recruited and randomized into two groups. They will receive either JPQC combined with mesalazine or mesalazine alone for 12 weeks. Follow-up visits will be conducted every four weeks, with a post-treatment visit scheduled at 6 months. The primary outcome measures include the Inflammatory bowel disease fatigue scale(IBD-F). Secondary efficacy indicators comprise the assessment of TCM syndrome and individual syndrome efficacy before and after treatment, Modified Mayo score, Simple clinical colitis activity index (SCCAI), as well as the Inflammatory Bowel Disease Questionnaire (IBDQ) for each group. The other outcomes are the Intestinal microbial diversity and non-targeted metabonomics, which will be measured at baseline and 12 weeks after randomization. DiscussionIf effective, JPQC will provide substantial clinical evidence concerning the effectiveness and safety in the treatment of patients with UC experiencing spleen deficiency and dampness-heat syndrome accompanied by fatigue. Trial registrationChiCTR2300068348.
ArticleNumber 101409
Author Zhang, Ya-Li
Zheng, Lie
Liu, Xiao-Yan
Liu, Zi-Xuan
Zhang, Wei-Bing
Tan, Wei-wei
Dai, Yan-Cheng
Author_xml – sequence: 1
  givenname: Zi-Xuan
  orcidid: 0009-0007-1980-5422
  surname: Liu
  fullname: Liu, Zi-Xuan
  organization: Department of Gastroenterology, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200082, China
– sequence: 2
  givenname: Xiao-Yan
  orcidid: 0000-0002-6605-7208
  surname: Liu
  fullname: Liu, Xiao-Yan
  organization: Department of Gastroenterology, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200082, China
– sequence: 3
  givenname: Wei-wei
  surname: Tan
  fullname: Tan, Wei-wei
  organization: Department of Gastroenterology, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200082, China
– sequence: 4
  givenname: Wei-Bing
  surname: Zhang
  fullname: Zhang, Wei-Bing
  organization: Department of Gastroenterology, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200082, China
– sequence: 5
  givenname: Ya-Li
  surname: Zhang
  fullname: Zhang, Ya-Li
  organization: Institute of Digestive Diseases, Long Hua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China
– sequence: 6
  givenname: Lie
  surname: Zheng
  fullname: Zheng, Lie
  email: liezhenglie@163.com
  organization: Department of Gastroenterology, Traditional Chinese Medicine Hospital of Shanxi Province, Xi'an, 710003, China
– sequence: 7
  givenname: Yan-Cheng
  surname: Dai
  fullname: Dai, Yan-Cheng
  email: daiyancheng2005@126.com
  organization: Department of Gastroenterology, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200082, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39735170$$D View this record in MEDLINE/PubMed
BookMark eNqVk81u1DAQxyNUREvpGyDkI5ctcRwnWYRAqOKjqBJCBYmb5Ywnu14cO9hOq_CivA5OU6r2gICT7fHM72_Px8NszzqLWfaY5sc0p9Wz3TE4CxGOi7woZ1OZr-9lB0XJ6aqpeLl3a7-fHYWwy_MUx2pa8AfZPlvXjNM6P8h-nhhtNUhDQhzVRFxHPmhpB00-abuBrbQbohAcRO0s0ZbELZLoUcYebZzdRwPoZdQXSMAZHXUgQzqm20AuddySMBhEmyidhmSGiUiriJL9YDGE1TaxSJis8q5HIgFcP0irUZF2Il0ibUZ8Ts6vXjd4F11SIZ3zRBKfQK7XP5JvSkf0zpi0jV5L8yi730kT8Oh6Pcy-vH3z-eT96uzju9OT12cr4E0dV7JsOWtZ29QN6xpV5hWvm7LraAmKNS2i4h3Ly4Ir2chqzRm2RUcryiRtqo4DO8xOF65ycicGr3vpJ-GkFlcG5zdC-qjBoOC8lg0HCsBkqap1y4DDGlhXV6osc5lYfGGNdpDTpTTmBkhzMddd7MRSdzHXXSx1T3GvlrhhbHtUkFLvpbnzmLs3Vm_Fxl0ISquGNjVPhKfXBO--jxii6HUANEZadGMQjPKcsqouZrEnt8VuVH63VHIoFwfwLgSP3b9-4uUShqlaFxq9CFfdgkp7hJjSqf8XANet_Q0nDDs3eps6QVARCpGL83k-5vEoyjQZvPqaAC_-DPi7_i8JIyfB
Cites_doi 10.1016/S0140-6736(23)00966-2
10.1038/s41575-018-0091-9
10.1111/apt.16145
10.1080/00365521.2021.1983640
10.1053/j.gastro.2021.08.060
10.1007/s12325-022-02364-2
10.1007/s11655-015-2118-1
10.1007/s40265-023-01888-3
10.1097/MIB.0000000000000314
10.1111/apt.16465
10.1097/MOG.0000000000000644
10.1016/j.clnesp.2017.10.004
10.1093/ibd/izad016
10.1093/ibd/izaa201
10.3390/foods10051030
10.1016/0016-5085(89)90905-0
10.1053/j.gastro.2022.08.050
10.1016/j.revmed.2023.05.007
10.1080/10408398.2021.1983768
10.3390/molecules27217377
10.1097/MD.0000000000006651
10.1186/s12916-022-02550-7
10.1053/j.gastro.2006.12.038
10.1136/gut.43.1.29
10.1016/j.cgh.2021.06.034
10.1186/s12876-022-02357-z
ContentType Journal Article
Copyright 2024 The Authors
The Authors
2024 The Authors. Published by Elsevier Inc.
2024 The Authors. Published by Elsevier Inc. 2024
Copyright_xml – notice: 2024 The Authors
– notice: The Authors
– notice: 2024 The Authors. Published by Elsevier Inc.
– notice: 2024 The Authors. Published by Elsevier Inc. 2024
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1016/j.conctc.2024.101409
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2451-8654
EndPage 101409
ExternalDocumentID oai_doaj_org_article_557a85c1cc3a4d69b3c5c9c3f76d440a
10.1016/j.conctc.2024.101409
PMC11681875
39735170
10_1016_j_conctc_2024_101409
S245186542400156X
1_s2_0_S245186542400156X
Genre Journal Article
GroupedDBID .1-
.FO
0R~
1P~
457
53G
AAEDW
AALRI
AAXUO
AAYWO
ABMAC
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEUPX
AEVXI
AEXQZ
AFJKZ
AFPUW
AFRHN
AFTJW
AGHFR
AIGII
AITUG
AJUYK
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
KQ8
M~E
O9-
OK1
ROL
RPM
SSZ
Z5R
0SF
6I.
AACTN
AAFTH
NCXOZ
AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c587t-a4b53b3b8783f8d4065784ff14cd38beed5f30425da8a6953eb2f1613a186f5c3
IEDL.DBID DOA
ISSN 2451-8654
IngestDate Wed Aug 27 01:31:09 EDT 2025
Tue Aug 19 09:00:38 EDT 2025
Tue Sep 30 17:06:41 EDT 2025
Fri Jul 11 16:02:49 EDT 2025
Sun Jan 05 01:57:19 EST 2025
Wed Oct 01 01:13:24 EDT 2025
Sat Jan 04 15:44:07 EST 2025
Tue Feb 25 19:58:24 EST 2025
Tue Aug 26 16:32:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Fatigue
Spleen deficiency and dampness-heat syndrome
Randomized controlled trial
Ulcerative colitis
Jianpi Qingchang decoction
Language English
License This is an open access article under the CC BY license.
2024 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c587t-a4b53b3b8783f8d4065784ff14cd38beed5f30425da8a6953eb2f1613a186f5c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors have contributed equally to this work and share first authorship.
ORCID 0009-0007-1980-5422
0000-0002-6605-7208
OpenAccessLink https://doaj.org/article/557a85c1cc3a4d69b3c5c9c3f76d440a
PMID 39735170
PQID 3150136729
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_557a85c1cc3a4d69b3c5c9c3f76d440a
unpaywall_primary_10_1016_j_conctc_2024_101409
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11681875
proquest_miscellaneous_3150136729
pubmed_primary_39735170
crossref_primary_10_1016_j_conctc_2024_101409
elsevier_sciencedirect_doi_10_1016_j_conctc_2024_101409
elsevier_clinicalkeyesjournals_1_s2_0_S245186542400156X
elsevier_clinicalkey_doi_10_1016_j_conctc_2024_101409
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-01
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Contemporary clinical trials communications
PublicationTitleAlternate Contemp Clin Trials Commun
PublicationYear 2024
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Li, Sun, Wang, Yang, Sun, Qu, Wang, Yang (bib36) 2022; 42
Varbobitis, Kokkotis, Gizis, Perlepe, Laoudi, Bletsa, Bekiari, Koutsounas, Kounadis, Xourafas, Lagou, Kolios, Papakonstantinou, Bamias (bib19) 2021; 27
Li, Li, Xu, Liu, Pang, Liao, Li, Shi (bib26) 2023; 63
Yamashita (bib27) 2020; 13
Qazi (bib25) 2020; 36
Lu, Liu, Wang, Wang (bib35) 2021; 10
Xie, Jiang, Wli, Liu, Chen, Huang, Huang (bib17) 2020; 32
Tang (bib37) 2021
Gasche, Ahmad, Tulassay, Baumgart, Bokemeyer, Buning, Howaldt, Stallmach (bib34) 2015; 21
Chen, Zhang, Zhang, Chen, Tang, Qiao, Dai, Tang (bib12) 2022; 2022
Shen, Tang, Tang, Zhang, Liu, Ye, Wen, Wang, Lu (bib16) 2019; 34
Danese, Tran, D'Haens, Rubin, Aoyama, Zhou, Ilo, Yao, Sanchez Gonzalez, Panaccione (bib31) 2023; 29
Dai, Zheng, Zhang, Chen, Chen, Tang (bib13) 2017; 96
D'Haens, Sandborn, Feagan, Geboes, Hanauer, Irvine, Lemann, Marteau, Rutgeerts, Scholmerich, Sutherland (bib15) 2007; 132
Keefer, Bedell, Norton, Hart (bib4) 2022; 162
Gramont, Goutte, Feasson, Millet, Hupin, Cathebras (bib3) 2023; 44
Xu, Hu, Yang, Ji, Cheng, Zhu, Shen (bib6) 2022; 22
Skjellerudsveen, Skoie, Dalen, Grimstad, Omdal (bib30) 2023; 83
Mcging, Radford, Francis, Serres, Greenhaff, Moran (bib5) 2021; 54
Regueiro, Hunter, Lukanova, Shan, Wild, Knight, Bannikoppa, Naegeli (bib7) 2023; 40
Dai, Zhang, Wang, Guo, Yang, Ye, Tang (bib11) 2016; 22
Zhang, Sheng, Zheng, Ye (bib9) 2017; 32
Walmsley, Ayres, Pounder, Allan (bib22) 1998; 43
Luo, Wei, Song, Xu, Huang, Fan, Zhang, Han, Lin (bib28) 2022; 27
Scholten, Vermeulen, Dhonukshe-Rutten, Verhagen, Visscher, Olivier, Timmer, Witteman (bib33) 2018; 23
Hua, Lin, Li, Dai (bib18) 2022; 17
Le Berre, Honap, Peyrin-Biroulet (bib1) 2023; 402
Shi (bib10) 2022
Guyatt, Mitchell, Irvine, Singer, Williams, Goodacre, Tompkins (bib20) 1989; 96
Thomann, Wustenberg, Wirbel, Knoedler, Thomann, Zeller, Ebert, Lis, Reindl (bib29) 2022; 20
Bager, Hvas, Rud, Dahlerup (bib32) 2022; 57
Zhang, Dai, Dai (bib21) 2011; 19
D Silva, Fox, Nasser, Vallance, Quinn, Ronksley, Raman (bib23) 2022; 20
Pekow (bib2) 2022; 163
Schreiner, Rossel, Biedermann, Valko, Baumann, Greuter, Scharl, Vavricka, Pittet, Juillerat, Rogler, von Känel, Misselwitz (bib24) 2021; 53
Borren, van der Woude, Ananthakrishnan (bib8) 2019; 16
Zhang, Dai, Dai, Chen, Chen, Tang (bib14) 2018; 26
Varbobitis (10.1016/j.conctc.2024.101409_bib19) 2021; 27
Zhang (10.1016/j.conctc.2024.101409_bib21) 2011; 19
Xu (10.1016/j.conctc.2024.101409_bib6) 2022; 22
Dai (10.1016/j.conctc.2024.101409_bib11) 2016; 22
Shi (10.1016/j.conctc.2024.101409_bib10) 2022
Gramont (10.1016/j.conctc.2024.101409_bib3) 2023; 44
Skjellerudsveen (10.1016/j.conctc.2024.101409_bib30) 2023; 83
Danese (10.1016/j.conctc.2024.101409_bib31) 2023; 29
Keefer (10.1016/j.conctc.2024.101409_bib4) 2022; 162
Hua (10.1016/j.conctc.2024.101409_bib18) 2022; 17
Zhang (10.1016/j.conctc.2024.101409_bib9) 2017; 32
Tang (10.1016/j.conctc.2024.101409_bib37) 2021
Pekow (10.1016/j.conctc.2024.101409_bib2) 2022; 163
Bager (10.1016/j.conctc.2024.101409_bib32) 2022; 57
Walmsley (10.1016/j.conctc.2024.101409_bib22) 1998; 43
D'Haens (10.1016/j.conctc.2024.101409_bib15) 2007; 132
Yamashita (10.1016/j.conctc.2024.101409_bib27) 2020; 13
Schreiner (10.1016/j.conctc.2024.101409_bib24) 2021; 53
Regueiro (10.1016/j.conctc.2024.101409_bib7) 2023; 40
Luo (10.1016/j.conctc.2024.101409_bib28) 2022; 27
Qazi (10.1016/j.conctc.2024.101409_bib25) 2020; 36
Thomann (10.1016/j.conctc.2024.101409_bib29) 2022; 20
Gasche (10.1016/j.conctc.2024.101409_bib34) 2015; 21
Guyatt (10.1016/j.conctc.2024.101409_bib20) 1989; 96
Borren (10.1016/j.conctc.2024.101409_bib8) 2019; 16
Scholten (10.1016/j.conctc.2024.101409_bib33) 2018; 23
Shen (10.1016/j.conctc.2024.101409_bib16) 2019; 34
Li (10.1016/j.conctc.2024.101409_bib26) 2023; 63
Chen (10.1016/j.conctc.2024.101409_bib12) 2022; 2022
Dai (10.1016/j.conctc.2024.101409_bib13) 2017; 96
Lu (10.1016/j.conctc.2024.101409_bib35) 2021; 10
Le Berre (10.1016/j.conctc.2024.101409_bib1) 2023; 402
Li (10.1016/j.conctc.2024.101409_bib36) 2022; 42
Xie (10.1016/j.conctc.2024.101409_bib17) 2020; 32
Mcging (10.1016/j.conctc.2024.101409_bib5) 2021; 54
Zhang (10.1016/j.conctc.2024.101409_bib14) 2018; 26
D Silva (10.1016/j.conctc.2024.101409_bib23) 2022; 20
References_xml – volume: 17
  start-page: 2057
  year: 2022
  end-page: 2061
  ident: bib18
  article-title: Effect of Jianpi Qingchang decoction on clinical Symptoms,Colon Lesions,and im-mune function of patients with ulcerative colitis
  publication-title: World Journal of Integrated Traditional and Western Medicine
– volume: 83
  start-page: 909
  year: 2023
  end-page: 921
  ident: bib30
  article-title: The effect of biological treatment on fatigue in inflammatory bowel disease: a systematic review and meta-analysis
  publication-title: Drugs
– year: 2021
  ident: bib37
  article-title: Gut Microbiota and Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored after Jianpi Qingchang Decoction Treatment
– volume: 13
  year: 2020
  ident: bib27
  article-title: Potential role of neuroactive tryptophan metabolites in central fatigue: establishment of the fatigue circuit
  publication-title: Int. J. Trypotophan Res.
– volume: 402
  start-page: 571
  year: 2023
  end-page: 584
  ident: bib1
  article-title: Ulcerative colitis
  publication-title: Lancet
– volume: 20
  start-page: 995
  year: 2022
  end-page: 1009
  ident: bib23
  article-title: Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis
  publication-title: Clin. Gastroenterol. Hepatol.
– volume: 27
  start-page: 7377
  year: 2022
  ident: bib28
  article-title: Interactions between gut microbiota and polyphenols: new insights into the treatment of fatigue
  publication-title: Molecules
– volume: 23
  start-page: 48
  year: 2018
  end-page: 53
  ident: bib33
  article-title: Surplus vitamin b12 use does not reduce fatigue in patients with irritable bowel syndrome or inflammatory bowel disease: a randomized double-blind placebo-controlled trial
  publication-title: Clin. Nutr. Espen
– volume: 26
  start-page: 929
  year: 2018
  end-page: 933
  ident: bib14
  article-title: Clinical assessment of Jianpi Qingchang formula in the treatment of ulcerative colitis patients with TCM type of spleen-deficiency and retention of damp-heat
  publication-title: Chin J Integr Trad West Med Dig.
– year: 2022
  ident: bib10
  article-title: The Comparative Study on the Clinical Characteristics of Fatigue between Large Intestine Dampness-Heat Syndrome and Spleen Deficiency Dampness Syndrome in Patients with Ulcerative Colitis
– volume: 44
  start-page: 662
  year: 2023
  end-page: 669
  ident: bib3
  article-title: [Chronic fatigue: what investigations? And what for?]
  publication-title: Rev. Med. Interne
– volume: 132
  start-page: 763
  year: 2007
  end-page: 786
  ident: bib15
  article-title: A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
  publication-title: Gastroenterology
– volume: 19
  start-page: 66
  year: 2011
  end-page: 68
  ident: bib21
  article-title: The digestive system disease professional committee of the Chinese association of integrated traditional Chinese and western medicine, Traditional Chinese Medicine Symptom Rating Scale for Gastrointestinal Diseases
  publication-title: Chin J Integr Trad West Med Dig
– volume: 2022
  year: 2022
  ident: bib12
  article-title: Jianpi Qingchang decoction ameliorates chronic colitis in piroxicam-induced IL-10 knockout mice by inhibiting endoplasmic reticulum stress
  publication-title: Evid Based Complement Alternat Med
– volume: 10
  start-page: 1030
  year: 2021
  ident: bib35
  article-title: Recent advances in panax ginseng c.a. Meyer as a herb for anti-fatigue: an effects and mechanisms review
  publication-title: Foods
– volume: 54
  start-page: 368
  year: 2021
  end-page: 387
  ident: bib5
  article-title: Review article: the aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies
  publication-title: Aliment. Pharmacol. Ther.
– volume: 34
  start-page: 4155
  year: 2019
  end-page: 4160
  ident: bib16
  article-title: Variation between observers in describing mucosal appearances in proctocolitis
  publication-title: Br. Med. J.
– volume: 36
  start-page: 284
  year: 2020
  end-page: 294
  ident: bib25
  article-title: Fatigue in inflammatory bowel disease: a problematic ailment
  publication-title: Curr. Opin. Gastroenterol.
– volume: 53
  start-page: 138
  year: 2021
  end-page: 149
  ident: bib24
  article-title: Fatigue in inflammatory bowel disease and its impact on daily activities
  publication-title: Aliment. Pharmacol. Ther.
– volume: 162
  start-page: 1439
  year: 2022
  end-page: 1451
  ident: bib4
  article-title: How should pain, fatigue, and emotional wellness be incorporated into treatment goals for optimal management of inflammatory bowel disease?
  publication-title: Gastroenterology
– volume: 20
  start-page: 366
  year: 2022
  ident: bib29
  article-title: Depression and fatigue in active IBD from a microbiome perspective-a bayesian approach to faecal metagenomics
  publication-title: BMC Med.
– volume: 43
  start-page: 29
  year: 1998
  end-page: 32
  ident: bib22
  article-title: A simple clinical colitis activity index
  publication-title: Gut
– volume: 22
  start-page: 811
  year: 2016
  end-page: 816
  ident: bib11
  article-title: Clinical presentation and treatment strategies for ulcerative colitis: a retrospective study of 247 inpatients
  publication-title: Chin. J. Integr. Med.
– volume: 32
  start-page: 767
  year: 2020
  end-page: 771
  ident: bib17
  article-title: Clinical study on treatment of left ulcerative colitis of spleen deficiency and damp-heat type by lichang decoction combined with ulcer ling
  publication-title: Clinical Journal of Traditional Chinese Medicine
– volume: 16
  start-page: 247
  year: 2019
  end-page: 259
  ident: bib8
  article-title: Fatigue in ibd: epidemiology, pathophysiology and management
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
– volume: 42
  start-page: 956
  year: 2022
  end-page: 960
  ident: bib36
  article-title: [Mechanism of acupuncture and moxibustion in treatment of chronic fatigue syndrome from perspective of intestinal flora]
  publication-title: Zhongguo Zhen Jiu
– volume: 63
  start-page: 3065
  year: 2023
  end-page: 3080
  ident: bib26
  article-title: Gut microbiota as a potential target for developing anti-fatigue foods
  publication-title: Crit. Rev. Food Sci. Nutr.
– volume: 22
  start-page: 281
  year: 2022
  ident: bib6
  article-title: Prevalence and factors associated with fatigue in patients with ulcerative colitis in China: a cross-sectional study
  publication-title: BMC Gastroenterol.
– volume: 32
  start-page: 3585
  year: 2017
  end-page: 3589
  ident: bib9
  article-title: Consensus opinion of traditional Chinese medicine diagnosis and treatment experts on ulcerative colitis (2017)
  publication-title: China Journal of Traditional Chinese Medicine and Pharmacy
– volume: 163
  start-page: 1164
  year: 2022
  end-page: 1165
  ident: bib2
  article-title: Fatigue in inflammatory bowel disease: a common complaint with few answers
  publication-title: Gastroenterology
– volume: 21
  start-page: 579
  year: 2015
  end-page: 588
  ident: bib34
  article-title: Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program
  publication-title: Inflamm. Bowel Dis.
– volume: 40
  start-page: 474
  year: 2023
  end-page: 488
  ident: bib7
  article-title: Burden of fatigue among patients with ulcerative colitis and crohn's disease: results from a global survey of patients and gastroenterologists
  publication-title: Adv. Ther.
– volume: 57
  start-page: 37
  year: 2022
  end-page: 43
  ident: bib32
  article-title: Long-term maintenance treatment with 300 mg thiamine for fatigue in patients with inflammatory bowel disease: results from an open-label extension of the tarif study
  publication-title: Scand. J. Gastroenterol.
– volume: 29
  start-page: 1723
  year: 2023
  end-page: 1729
  ident: bib31
  article-title: Upadacitinib induction and maintenance therapy improves abdominal pain, bowel urgency, and fatigue in patients with ulcerative colitis: a post hoc analysis of phase 3 data
  publication-title: Inflamm. Bowel Dis.
– volume: 27
  start-page: 826
  year: 2021
  end-page: 835
  ident: bib19
  article-title: The ibd-f patient self-assessment scale accurately depicts the level of fatigue and predicts a negative effect on the quality of life of patients with ibd in clinical remission
  publication-title: Inflamm. Bowel Dis.
– volume: 96
  year: 2017
  ident: bib13
  article-title: Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: a randomized controlled trial
  publication-title: Medicine. (Baltimore)
– volume: 96
  start-page: 804
  year: 1989
  ident: bib20
  article-title: A new measure of health status for clinical trials in inflammatory bowel disease
  publication-title: Gastroenterolog
– volume: 402
  start-page: 571
  year: 2023
  ident: 10.1016/j.conctc.2024.101409_bib1
  article-title: Ulcerative colitis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(23)00966-2
– volume: 17
  start-page: 2057
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib18
  article-title: Effect of Jianpi Qingchang decoction on clinical Symptoms,Colon Lesions,and im-mune function of patients with ulcerative colitis
  publication-title: World Journal of Integrated Traditional and Western Medicine
– year: 2021
  ident: 10.1016/j.conctc.2024.101409_bib37
– volume: 16
  start-page: 247
  year: 2019
  ident: 10.1016/j.conctc.2024.101409_bib8
  article-title: Fatigue in ibd: epidemiology, pathophysiology and management
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/s41575-018-0091-9
– volume: 42
  start-page: 956
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib36
  article-title: [Mechanism of acupuncture and moxibustion in treatment of chronic fatigue syndrome from perspective of intestinal flora]
  publication-title: Zhongguo Zhen Jiu
– volume: 53
  start-page: 138
  year: 2021
  ident: 10.1016/j.conctc.2024.101409_bib24
  article-title: Fatigue in inflammatory bowel disease and its impact on daily activities
  publication-title: Aliment. Pharmacol. Ther.
  doi: 10.1111/apt.16145
– volume: 19
  start-page: 66
  year: 2011
  ident: 10.1016/j.conctc.2024.101409_bib21
  article-title: The digestive system disease professional committee of the Chinese association of integrated traditional Chinese and western medicine, Traditional Chinese Medicine Symptom Rating Scale for Gastrointestinal Diseases
  publication-title: Chin J Integr Trad West Med Dig
– volume: 57
  start-page: 37
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib32
  article-title: Long-term maintenance treatment with 300 mg thiamine for fatigue in patients with inflammatory bowel disease: results from an open-label extension of the tarif study
  publication-title: Scand. J. Gastroenterol.
  doi: 10.1080/00365521.2021.1983640
– volume: 162
  start-page: 1439
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib4
  article-title: How should pain, fatigue, and emotional wellness be incorporated into treatment goals for optimal management of inflammatory bowel disease?
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2021.08.060
– volume: 40
  start-page: 474
  year: 2023
  ident: 10.1016/j.conctc.2024.101409_bib7
  article-title: Burden of fatigue among patients with ulcerative colitis and crohn's disease: results from a global survey of patients and gastroenterologists
  publication-title: Adv. Ther.
  doi: 10.1007/s12325-022-02364-2
– volume: 22
  start-page: 811
  year: 2016
  ident: 10.1016/j.conctc.2024.101409_bib11
  article-title: Clinical presentation and treatment strategies for ulcerative colitis: a retrospective study of 247 inpatients
  publication-title: Chin. J. Integr. Med.
  doi: 10.1007/s11655-015-2118-1
– volume: 34
  start-page: 4155
  year: 2019
  ident: 10.1016/j.conctc.2024.101409_bib16
  article-title: Variation between observers in describing mucosal appearances in proctocolitis
  publication-title: Br. Med. J.
– volume: 83
  start-page: 909
  year: 2023
  ident: 10.1016/j.conctc.2024.101409_bib30
  article-title: The effect of biological treatment on fatigue in inflammatory bowel disease: a systematic review and meta-analysis
  publication-title: Drugs
  doi: 10.1007/s40265-023-01888-3
– volume: 21
  start-page: 579
  year: 2015
  ident: 10.1016/j.conctc.2024.101409_bib34
  article-title: Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program
  publication-title: Inflamm. Bowel Dis.
  doi: 10.1097/MIB.0000000000000314
– volume: 54
  start-page: 368
  year: 2021
  ident: 10.1016/j.conctc.2024.101409_bib5
  article-title: Review article: the aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies
  publication-title: Aliment. Pharmacol. Ther.
  doi: 10.1111/apt.16465
– volume: 32
  start-page: 3585
  year: 2017
  ident: 10.1016/j.conctc.2024.101409_bib9
  article-title: Consensus opinion of traditional Chinese medicine diagnosis and treatment experts on ulcerative colitis (2017)
  publication-title: China Journal of Traditional Chinese Medicine and Pharmacy
– volume: 2022
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib12
  article-title: Jianpi Qingchang decoction ameliorates chronic colitis in piroxicam-induced IL-10 knockout mice by inhibiting endoplasmic reticulum stress
  publication-title: Evid Based Complement Alternat Med
– volume: 36
  start-page: 284
  year: 2020
  ident: 10.1016/j.conctc.2024.101409_bib25
  article-title: Fatigue in inflammatory bowel disease: a problematic ailment
  publication-title: Curr. Opin. Gastroenterol.
  doi: 10.1097/MOG.0000000000000644
– volume: 23
  start-page: 48
  year: 2018
  ident: 10.1016/j.conctc.2024.101409_bib33
  article-title: Surplus vitamin b12 use does not reduce fatigue in patients with irritable bowel syndrome or inflammatory bowel disease: a randomized double-blind placebo-controlled trial
  publication-title: Clin. Nutr. Espen
  doi: 10.1016/j.clnesp.2017.10.004
– year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib10
– volume: 26
  start-page: 929
  year: 2018
  ident: 10.1016/j.conctc.2024.101409_bib14
  article-title: Clinical assessment of Jianpi Qingchang formula in the treatment of ulcerative colitis patients with TCM type of spleen-deficiency and retention of damp-heat
  publication-title: Chin J Integr Trad West Med Dig.
– volume: 29
  start-page: 1723
  year: 2023
  ident: 10.1016/j.conctc.2024.101409_bib31
  article-title: Upadacitinib induction and maintenance therapy improves abdominal pain, bowel urgency, and fatigue in patients with ulcerative colitis: a post hoc analysis of phase 3 data
  publication-title: Inflamm. Bowel Dis.
  doi: 10.1093/ibd/izad016
– volume: 32
  start-page: 767
  year: 2020
  ident: 10.1016/j.conctc.2024.101409_bib17
  article-title: Clinical study on treatment of left ulcerative colitis of spleen deficiency and damp-heat type by lichang decoction combined with ulcer ling
  publication-title: Clinical Journal of Traditional Chinese Medicine
– volume: 27
  start-page: 826
  year: 2021
  ident: 10.1016/j.conctc.2024.101409_bib19
  article-title: The ibd-f patient self-assessment scale accurately depicts the level of fatigue and predicts a negative effect on the quality of life of patients with ibd in clinical remission
  publication-title: Inflamm. Bowel Dis.
  doi: 10.1093/ibd/izaa201
– volume: 10
  start-page: 1030
  year: 2021
  ident: 10.1016/j.conctc.2024.101409_bib35
  article-title: Recent advances in panax ginseng c.a. Meyer as a herb for anti-fatigue: an effects and mechanisms review
  publication-title: Foods
  doi: 10.3390/foods10051030
– volume: 13
  year: 2020
  ident: 10.1016/j.conctc.2024.101409_bib27
  article-title: Potential role of neuroactive tryptophan metabolites in central fatigue: establishment of the fatigue circuit
  publication-title: Int. J. Trypotophan Res.
– volume: 96
  start-page: 804
  year: 1989
  ident: 10.1016/j.conctc.2024.101409_bib20
  article-title: A new measure of health status for clinical trials in inflammatory bowel disease
  publication-title: Gastroenterolog
  doi: 10.1016/0016-5085(89)90905-0
– volume: 163
  start-page: 1164
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib2
  article-title: Fatigue in inflammatory bowel disease: a common complaint with few answers
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2022.08.050
– volume: 44
  start-page: 662
  year: 2023
  ident: 10.1016/j.conctc.2024.101409_bib3
  article-title: [Chronic fatigue: what investigations? And what for?]
  publication-title: Rev. Med. Interne
  doi: 10.1016/j.revmed.2023.05.007
– volume: 63
  start-page: 3065
  year: 2023
  ident: 10.1016/j.conctc.2024.101409_bib26
  article-title: Gut microbiota as a potential target for developing anti-fatigue foods
  publication-title: Crit. Rev. Food Sci. Nutr.
  doi: 10.1080/10408398.2021.1983768
– volume: 27
  start-page: 7377
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib28
  article-title: Interactions between gut microbiota and polyphenols: new insights into the treatment of fatigue
  publication-title: Molecules
  doi: 10.3390/molecules27217377
– volume: 96
  year: 2017
  ident: 10.1016/j.conctc.2024.101409_bib13
  article-title: Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: a randomized controlled trial
  publication-title: Medicine. (Baltimore)
  doi: 10.1097/MD.0000000000006651
– volume: 20
  start-page: 366
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib29
  article-title: Depression and fatigue in active IBD from a microbiome perspective-a bayesian approach to faecal metagenomics
  publication-title: BMC Med.
  doi: 10.1186/s12916-022-02550-7
– volume: 132
  start-page: 763
  year: 2007
  ident: 10.1016/j.conctc.2024.101409_bib15
  article-title: A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.12.038
– volume: 43
  start-page: 29
  year: 1998
  ident: 10.1016/j.conctc.2024.101409_bib22
  article-title: A simple clinical colitis activity index
  publication-title: Gut
  doi: 10.1136/gut.43.1.29
– volume: 20
  start-page: 995
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib23
  article-title: Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis
  publication-title: Clin. Gastroenterol. Hepatol.
  doi: 10.1016/j.cgh.2021.06.034
– volume: 22
  start-page: 281
  year: 2022
  ident: 10.1016/j.conctc.2024.101409_bib6
  article-title: Prevalence and factors associated with fatigue in patients with ulcerative colitis in China: a cross-sectional study
  publication-title: BMC Gastroenterol.
  doi: 10.1186/s12876-022-02357-z
SSID ssj0001637125
Score 2.283904
Snippet Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional...
AbstractBackgroundUlcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in...
Background: Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under ''dysentery'' and ''intestinal bleeding'' in...
SourceID doaj
unpaywall
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 101409
SubjectTerms Fatigue
Jianpi Qingchang decoction
Other
Randomized controlled trial
Spleen deficiency and dampness-heat syndrome
Ulcerative colitis
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLamTgJeuF_KTQeJR1LV8SUObwMxTZM6gUal8mQ5jg2FLq1IK7T9Uf4Ox05SLQxEeWtTX5qc2-f4nM-EvJQyo55lLkGw4RPupE3ysXGJ8znKHJdyLJK4Tk7k0ZQfz8Rsj7zqamF6-_cxDwuXhTaSDaY8XOKhWm9fhu2kAdmfnrw_-BTOj-OCJkoK3lXH_aVrL_pEkv5eELoKMq_mSl7fVCtz_sMsFpcC0eEtMuluock_-TbarIuRvfiN3XHXe7xNbraIFA4aFbpD9lx1l1ybtHvu98jPljp0AZGKFpYejlGnVnP4gGEvFg5DiYvYWCAB8woQUsI2fz003yysawjGwcZ0uxpaOtcawntgqFchoQNHCXQWoRYUTFVCac5WwREnIV5AR60Axsa8-QqxMxTn4HGkzxv3Gk7jvwu8E0ucBRCMgwGMxOXybH6Bbduk_AV-jEeV3CfTw3cf3x4l7XEQiRUqWyeGF4IVrFCZYl6ViETQ23DvKbclUwUGe-HDyxlRGmVkLhhqmkdAywxV0gvLHpBBtazcIwKFyp2SJkvLlHLnVaGct5J6XlLjVFoMSdKpiV41rB-6S4f7qhtp6SAt3UhrSN4EXdq2DZzd8QKKWbcuQAuRGSUstZYZXsq8YFbY3DKfyZLzsRkS0Wmi7spi0ZHjQPN_TJ79qZ-rW29Ua6rrVI_1abCSYCQhbxjX7bPLPVvA1QCpHeZ80ZmKRn8UNplM5ZabWjM0-kADmGKbh43pbB8LYl8maDYeEtUzqt5z6_9Szb9EznNKJULLTAzJaGt_O4nm8f92eEJuhG9NytJTMlh_37hnCDzXxfPW3_wCdKKFKg
  priority: 102
  providerName: Unpaywall
Title Clinical study of Jianpi Qingchang decoction in the treatment of ulcerative colitis patients with spleen deficiency and dampness-heat syndrome accompanied by fatigue: Study protocol for a randomized controlled trial
URI https://www.clinicalkey.com/#!/content/1-s2.0-S245186542400156X
https://www.clinicalkey.es/playcontent/1-s2.0-S245186542400156X
https://dx.doi.org/10.1016/j.conctc.2024.101409
https://www.ncbi.nlm.nih.gov/pubmed/39735170
https://www.proquest.com/docview/3150136729
https://pubmed.ncbi.nlm.nih.gov/PMC11681875
https://doi.org/10.1016/j.conctc.2024.101409
https://doaj.org/article/557a85c1cc3a4d69b3c5c9c3f76d440a
UnpaywallVersion publishedVersion
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2451-8654
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001637125
  issn: 2451-8654
  databaseCode: KQ8
  dateStart: 20151030
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2451-8654
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001637125
  issn: 2451-8654
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2451-8654
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001637125
  issn: 2451-8654
  databaseCode: M~E
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2451-8654
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001637125
  issn: 2451-8654
  databaseCode: RPM
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwGLXQkIAXxJ1ymT4kXgN1fA1vAzFNkzaBRqXyZDm-QFGXVqQVGn-Uv8NnJ6laDWl74K1KHae1j7_v2Dk-JuS1lIpGpkKBZCMWPEhXVGMbihAr7HOcyrFs4npyKo8m_HgqpltHfSVNWGcP3DXcWyGU1cJR55jlXlY1c8JVjkUlPefjTI0wjW1NpvLqimQKU_ewVy4LunB-6bJrYcnTJZ40iFu5KFv276Sky5TzsnLy9rpZ2otfdj7fSkuH98jdnk_CQfc_7pMboXlAbp30b8wfkj-98eccspEsLCIcIyKWM_iMSStv-wWPU9C8vQFmDSAhhI36PBVfz13o7MHBZbFcC70ZawtpFRfaZZJjYC3JjCLt5ATbePD2fJnCaJGiPQzGCGBdVr03yHyhvoCINX1bh3dwln9dco1Y4FMAqTRYwDzqF-ez31i2l9TP8WM-aOQRmRx-_PLhqOgPcyic0GpVWF4LVrNaK82i9sgjMFbwGCl3nukaU7WIaWlFeKutrARDnESko8xSLaNw7DHZaxZNeEqg1lXQ0qrSl5SHqGsdopM0ck9t0GU9IsXQrWbZeXaYQcz2w3QwMAkGpoPBiLxPfb8pmxy38wXEoelxaK7C4YiIATlm2NSKYRgrml3xcPWv-0Lbx5LWUNOWZmzOSi6wKQRPql-cdU-37-zpUkeDrvHMVwO0DUaT9IrINmGxbg3DIZtM_Eos86SD-qZZkLkyQdV4RPTOINhpt91vmtn37FhOqURiqMSIvNmMl2t1zbP_0TXPyZ1UZSdCekH2Vj_X4SVSyVW9n6PGPrk5Of108PUv2XN6ag
linkProvider Directory of Open Access Journals
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLamTgJeuF_KTQeJR1LV8SUObwMxTZM6gUal8mQ5jg2FLq1IK7T9Uf4Ox05SLQxEeWtTX5qc2-f4nM-EvJQyo55lLkGw4RPupE3ysXGJ8znKHJdyLJK4Tk7k0ZQfz8Rsj7zqamF6-_cxDwuXhTaSDaY8XOKhWm9fhu2kAdmfnrw_-BTOj-OCJkoK3lXH_aVrL_pEkv5eELoKMq_mSl7fVCtz_sMsFpcC0eEtMuluock_-TbarIuRvfiN3XHXe7xNbraIFA4aFbpD9lx1l1ybtHvu98jPljp0AZGKFpYejlGnVnP4gGEvFg5DiYvYWCAB8woQUsI2fz003yysawjGwcZ0uxpaOtcawntgqFchoQNHCXQWoRYUTFVCac5WwREnIV5AR60Axsa8-QqxMxTn4HGkzxv3Gk7jvwu8E0ucBRCMgwGMxOXybH6Bbduk_AV-jEeV3CfTw3cf3x4l7XEQiRUqWyeGF4IVrFCZYl6ViETQ23DvKbclUwUGe-HDyxlRGmVkLhhqmkdAywxV0gvLHpBBtazcIwKFyp2SJkvLlHLnVaGct5J6XlLjVFoMSdKpiV41rB-6S4f7qhtp6SAt3UhrSN4EXdq2DZzd8QKKWbcuQAuRGSUstZYZXsq8YFbY3DKfyZLzsRkS0Wmi7spi0ZHjQPN_TJ79qZ-rW29Ua6rrVI_1abCSYCQhbxjX7bPLPVvA1QCpHeZ80ZmKRn8UNplM5ZabWjM0-kADmGKbh43pbB8LYl8maDYeEtUzqt5z6_9Szb9EznNKJULLTAzJaGt_O4nm8f92eEJuhG9NytJTMlh_37hnCDzXxfPW3_wCdKKFKg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+study+of+Jianpi+Qingchang+decoction+in+the+treatment+of+ulcerative+colitis+patients+with+spleen+deficiency+and+dampness-heat+syndrome+accompanied+by+fatigue%3A+Study+protocol+for+a+randomized+controlled+trial&rft.jtitle=Contemporary+clinical+trials+communications&rft.au=Liu%2C+Zi-Xuan&rft.au=Liu%2C+Xiao-Yan&rft.au=Tan%2C+Wei-Wei&rft.au=Zhang%2C+Wei-Bing&rft.date=2024-12-01&rft.eissn=2451-8654&rft.volume=42&rft.spage=101409&rft_id=info:doi/10.1016%2Fj.conctc.2024.101409&rft_id=info%3Apmid%2F39735170&rft.externalDocID=39735170
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F24518654%2FS2451865424X00058%2Fcov150h.gif